Safety evaluation and adverse events monitoring by poison control centers: A framework for herbs & dietary supplements

Clinical Toxicology

Volumn 44, Issue 5, 2006, Pages 617-622

  Woolf, Alan D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AYURVEDIC DRUG; BETAINE; EPHEDRINE; GINGER EXTRACT; HERBACEOUS AGENT; LITHIUM DERIVATIVE; NICOTINAMIDE; ORNITHINE; PANTOTHENIC ACID; PARACETAMOL; PEPPERMINT; THIOCTIC ACID; YOHIMBINE;

AYURVEDA; CHINESE HERB; CONFERENCE PAPER; CONSUMER; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HERB; HUMAN; POISON CENTER; POSTMARKETING SURVEILLANCE; RISK ASSESSMENT;

DIETARY SUPPLEMENTS; HUMANS; LEGISLATION, DRUG; PLANT PREPARATIONS; POISON CONTROL CENTERS;

EID: 33747256269     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600795578     Document Type: Conference Paper

References (32)

1. Morrow JD, Edeki TI, El Mouelhi M, Galinsky RE, Kovelesky R, Noveck RJ, Preuss C. Am Soc for Clin Pharmacol and Therapeutics Task Force on Dietary Supplements. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 2005; 77:113-122.
2. MBJ's Annual Industry Review. VII. Nutrition Business Journal. 2002; May/June.
3. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Advance Data From Vital and Health Statistics, Centers for Disease Control, DHHS, Number 323, May 27, 2004.
4. Anonymous. Dangerous supplements: still at large. Consumer Reports 2004; May 4.
5. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73:1101-1106.
6. Anonymous. Dietary Supplement Health and Education Act (DSHEA), Public Law 103-417, 1994. Act 21 U.S.C. 350 b [c].
7. Food & Drug Administration, Department of Health & Human Services. Medwatch Program. (Accessed December 30, 2005 at http://www.fda.gov/ medwatch.html)
8. Anonymous. FDA proposes manufacturing and labeling standards for all dietary supplements. March 7, 2003. (Accessed March 19, 2003 at http://www.fda.gov/bbs/topics/NEWS/dietarysupp/background.html)
9. Anonymous. Dietary supplements: warnings and safety information. College Park, Maryland: FDA Center for Food Safety and Applied Nutrition. (Accessed December 30, 2005 at http://www.cfsan.fda.gov/-dms/ds.warn.html)
10. Marcus DM, Grollman AP. Botanical medicines - the need for new regulations. N Engl J Med 2002; 347:2073-2076.
11. Morrow JD, Edeki T, Mouelhi ME, Galinsky RE, Kovelesky R, et al. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 2005; 77:113-122.
12. Committee on the Framework for Evaluating the Safety of Dietary Supplements. Institute of Medicine & National Research Council. Dietary Supplements: A Framework for Evaluating Safety. Washington D.C.: The National Academies Press, 2005.
13. Leape L. Reporting of adverse events. N Engl J Med 2002; 347:1633-1638.
14. Inspector General Report: adverse event reporting for dietary supplements: an inadequate safety valve. Washington D.C. Office of the Inspector General. DHHS. 2001 April, report number OEI-01-00-00 180.
15. Woolf AD, Litovitz T. Reporting of adverse events. N Engl J Med 2003; 348:1410-1411.
16. Litovitz T. The TESS database: use in product safety assessment. Drug Safety 1998; 18:9-19.
17. Dennehy CE, Psourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Heal-Syst Pharm 2005; 62:1476-1482.
18. Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A, Sprague BM, Ko R, Everson G, Nelson LS, Dodd-Butera T, Bartlett WD, Landzberg BR. Adverse events associated with dietary supplements: an observational study. Lancet 2003; 361:101-106.
19. Binscheck T, Birkhahn HJ, Felgenhauer N, Gerber-Zupan G, Zilker T, Hentschel H, Lampe D. Intoxication with alpha-lipoic acid: case reports and toxico kinetic analysis. Clin Toxicol 2005; 43:422.
20. Bacis G, Farina ML. Liver transplantation for acute cholestatic hepatitis after herbal tea use. Clin Toxicol 2005; 43:470.
21. Moltz E, Marshall S, Andrenyak D, Couch D, Mon M, Caravati EM, Crouch BI. Strychnine poisoning following ingestion of a Chinese herbal liniment. Clin Toxicol 2005; 43:645.
22. Dargan PI, Greene SL, House IM, Jones AL. Two cases of lead poisoning from Ayurvedic medicine: the tip of the iceberg? Clin Toxicol 2005; 43:652.
23. Dargan PI, Dhiew CM, Greene SL, Jones AL. Yohimbine poisoning from slimming pills bought over the Internet. Clin Toxicol 2005; 43:661.
24. DeBellonia RR, Marcus S, Ruck B, Rella JG, Shih RD. Curandismo: consequences of folk medicine. Clin Toxicol 2005; 43:704.
25. Cumpston KL, Goldstein L, Monge T, Cano D. Hepatic and pulmonary veno-occlusive disease in siblings administered ELTHCHO tea. Clin Toxicol 2005; 43:763.
26. Pauze DK, Humberston L, Brooks DE, Katz KD. Lithium toxicity from an Internet dietary supplement. Clin Toxicol 2005; 43:761.
27. Smith SW, Halcomb SE, Hoffman RS, Nelson LS. A report of lupinus mutabilis anticholinergic toxicity. Clin Toxicol 2005; 43:763.
28. Maloney GE, Rhee JW, Schuermann T, Saeedi B, Leikin JB. Fulminant hepatic failure after using reported herbal medication containing high levels of acetaminophen. Clin Toxicol 2005; 43:760.
29. Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666.
30. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003; 138:468-471.
31. Woolf AD, Litovtz T, Smolinske S, Watson W. The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002. Clin Toxicol 2005; 43 (5):347-355.
32. Kingston R, Blumenthal M. A rational perspective on adverse events reports on herbs: misinterpretation of adverse reactions tabulated in the TESS Annual Report of the AAPCC as they relate to ephedra dietary supplements. Herbalgram 2003; 60:48-53.